Headline News about Travere Therapeutics Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Travere Therapeutics
February 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Where Travere Therapeutics Stands With Analysts
December 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/05/ai-generated-8210911_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where Travere Therapeutics Stands With Analysts
November 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/21/calt.png?width=1200&height=800&fit=crop)
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/12/06/thor_industries_-_logo_0.jpg?width=1200&height=800&fit=crop)
THOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
December 06, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/05/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/daktronics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/05/nio_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for Travere Therapeutics
September 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/22/micron_-_logo_copy.jpg?width=1200&height=800&fit=crop)
Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday
September 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Preview: Travere Therapeutics's Earnings
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/21/tvtx_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/21/darden_-_logo_0.jpg?width=1200&height=800&fit=crop)
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/21/image45.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/748438/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://www.investors.com/wp-content/uploads/2017/10/Stock-biotechLab-01-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.